| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.014 | 0.8 |